OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

OBJECTIVE: Chronic migraine (CM) is a prevalent and disabling neurological disorder. Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical program assessed efficacy and safety of onabotulinumtoxinA (BOTOX®) for prophylaxis of headaches in adults with CM. This secondary analys...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Aurora, SK, Dodick, DW, Diener, H-C, DeGryse, RE, Turkel, CC, Lipton, RB, Silberstein, SD
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033567/
https://ncbi.nlm.nih.gov/pubmed/24107267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ane.12171
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items